$AKTX News Article - Akari Therapeutics announces new data demonstrating synergistic benefits of nomacopan's bifunctional C5 and LTB4 inhibitory activity in pemphigoid disease https://marketwirenews.com/news-releases/akar...22239.html
(1)
(0)
Akari Therapeutics Plc (AKTX) Stock Research Links